PROCEPT BioRobotics Corporation Common Stock

PRCTNASDAQ • USD
17.16 USD
↗ 0.14 (0.82%)AT CLOSE (03:59 PM EDT)
17.17
↗ 0.01 (0.03%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
17.17
↗ 0.01 (0.03%)
🔴Market: CLOSED

PRCT is currently priced at $17.16. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest PRCT is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 2, 2026.

Open?$17.19
High?$17.91
Low?$16.95
Prev. Close?$17.02
Volume?1.2M
Avg. Volume?1.3M
VWAP?$17.28
Rel. Volume?0.99x
Bid / Ask
Bid?$14.43 × 100
Ask?$19.85 × 100
Spread?$5.42
Midpoint?$17.14
Valuation & Ratios
Market Cap?982.8M
Shares Out?57.3M
Float?52.9M
Float %?92.9%
P/E Ratio?N/A
P/B Ratio?2.89
EPS?-$1.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Employees
888
Market Cap
982.8M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-09-15
Address
150 BAYTECH DRIVE
SAN JOSE, CA 95134
Phone: (650) 232-9832
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
71
Momentum?
40
Short Sent.?
60
Piotroski F-Score?1/9Weak
Altman Z-Score?3.00Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.06%High
Short Interest?7.4M
Days to Cover?5.6
Free Float52.9M
Avg Daily Volume1.3M
Settlement Date2026-09-15
Financial Health
Current Ratio?6.55Strong
Quick Ratio?5.35Strong
Cash Ratio?3.55Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
58
2.89CHEAP▾
P/S?
Peers
100
S&P
52
2.91CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.5CHEAP▾
EV/Sales?
Peers
100
S&P
69
2.39CHEAP▾
Returns & Efficiency
ROE?
S&P
6
-32.3%WEAK▾
ROA?
S&P
3
-22.9%WEAK▾
Cash Flow & Enterprise
FCF?$-84925000
Enterprise Value?$806.6M
Fundamentals ratios updated end of day